User menu

Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study.

Bibliographic reference Bosly, André ; Sonet, Anne ; Pinkerton, C Ross ; McCowage, Geoffrey ; Bron, Dominique ; et. al. Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study.. In: Cancer, Vol. 98, no. 5, p. 1048-54 (2003)
Permanent URL http://hdl.handle.net/2078.1/27438
  1. Goldman, Blood., 97, 2998 (2001)
  2. Tumor lysis syndrome. In: editor. Clinical oncology (2nd edition). New York: Churchill Livingstone, 2000: 750-754.
  3. Altman, Semin Oncol., 28, 3 (2001)
  4. Sallan, Semin Oncol., 28, 9 (2001)
  5. Smalley, J Clin Oncol., 18, 1758 (2000)
  6. Zyloric. Summary of product characteristics [monograph online]. Available from URL:
  7. Band, N Engl J Med., 283, 354 (1970)
  8. Andreoli, J Pediatr., 109, 292 (1986)
  9. Masera, J Pediatr., 100, 152 (1982)
  10. Leach, Clin Lab Haematol., 20, 169 (1998)
  11. Brogard, Rev Eur Etud Clin Biol., 17, 890 (1972)
  12. Patte, Ann Oncol., 13, 789 (2002)
  13. Pui, J Clin Oncol., 19, 697 (2001)
  14. Pui, Leukemia., 15, 1505 (2001)
  15. Pui, Blood., 100, 556a (2002)
  16. Pui, Leukemia., 11, 1813 (1997)
  17. Coiffier, Blood., 100, 359a (2002)
  18. Dann, J Clin Oncol., 20, 354 (2002)
  19. Vora, Ann Oncol., 13, 1833 (2002)
  20. Jensen, Ann Hematol., 77, 89 (1998)
  21. Yang, Am J Hematol., 62, 247 (1998)
  22. Anderson, J Miss State Med Assoc., 43, 105 (2002)
  23. Pui, Expert Opin Pharmacother., 3, 433 (2002)